Department of Medicine, Center for Liver Disease and Transplantation, NY-Presbyterian Hospital, Columbia University Medical Center, Columbia University College of Physicians and Surgeons, PH-14 622 West 168th Street, New York, NY 10032, USA.
Department of Medicine, Center for Liver Disease and Transplantation, NY-Presbyterian Hospital, Columbia University Medical Center, Columbia University College of Physicians and Surgeons, PH-14 622 West 168th Street, New York, NY 10032, USA.
Clin Liver Dis. 2020 May;24(2):277-290. doi: 10.1016/j.cld.2020.01.007. Epub 2020 Feb 26.
Hepatic encephalopathy (HE) is a frequent indication for hospitalization and represents a common manifestation of portal hypertension and decompensated liver disease that contributes to hospital readmissions. Multiple new techniques are being evaluated to assist in preventing readmissions in these high-risk patients. Techniques to improve medication adherence are paramount. The use of telemedicine and on-demand patient assessment is likely to diminish hospitalizations for HE. Wearable technology has the potential to assist in HE diagnosis and prevent HE progression, with an anticipated diminution in hospital readmissions. This article discusses current and potential future techniques to improve outcomes in these vulnerable patients.
肝性脑病(HE)是住院的常见指征,也是门脉高压和肝功能失代偿的常见表现,可导致患者再次住院。目前正在评估多种新技术以帮助预防这些高危患者的再入院。改善药物依从性的技术至关重要。使用远程医疗和按需患者评估可能会减少 HE 的住院治疗。可穿戴技术有可能协助诊断 HE 并防止其进展,预计可减少医院的再入院率。本文讨论了目前和未来可能改善这些脆弱患者预后的技术。